Exelixis Stock Z Score

EXEL Stock

USD 28.83 0.17 0.59%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Exelixis Piotroski F Score and Exelixis Valuation analysis.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

At this time, Exelixis' Capital Expenditure Coverage Ratio is quite stable compared to the past year. At this time, Exelixis' EBIT is quite stable compared to the past year. Research Development is expected to rise to about 1.1 B this year, although the value of Net Income From Continuing Ops will most likely fall to about 81 M.

Exelixis Company Z Score Analysis

Exelixis' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Exelixis Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Exelixis is extremely important. It helps to project a fair market value of Exelixis Stock properly, considering its historical fundamentals such as Z Score. Since Exelixis' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Exelixis' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Exelixis' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Retained Earnings	Net Debt	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Good Will	Intangible Assets	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.72	-0.68	0.95	0.94	0.96	0.34	0.96	-0.34	-0.33	-0.55	-0.26	-0.43	0.94	-0.09	0.99	-0.69	0.83	0.78	0.93	-0.59	0.97	0.91	0.78
Total Stockholder Equity	0.99		0.78	-0.76	0.92	0.95	0.97	0.2	0.97	-0.39	-0.26	-0.61	-0.25	-0.39	0.94	-0.03	0.99	-0.73	0.81	0.79	0.9	-0.64	0.99	0.94	0.75
Retained Earnings	0.72	0.78		-0.61	0.67	0.69	0.69	-0.18	0.68	-0.6	0.34	-0.58	-0.53	-0.48	0.78	-0.05	0.78	-0.53	0.39	0.44	0.73	-0.61	0.78	0.75	0.59
Net Debt	-0.68	-0.76	-0.61		-0.55	-0.82	-0.76	0.15	-0.82	0.4	0.07	0.77	-0.04	-0.01	-0.74	-0.1	-0.67	0.82	-0.67	-0.77	-0.46	0.64	-0.76	-0.83	-0.46
Accounts Payable	0.95	0.92	0.67	-0.55		0.89	0.89	0.43	0.88	-0.26	-0.25	-0.49	-0.39	-0.54	0.92	-0.3	0.94	-0.61	0.79	0.72	0.91	-0.51	0.9	0.84	0.8
Net Receivables	0.94	0.95	0.69	-0.82	0.89		0.91	0.21	0.95	-0.32	-0.28	-0.66	-0.25	-0.39	0.97	-0.12	0.94	-0.78	0.83	0.84	0.79	-0.62	0.93	0.92	0.72
Short Term Investments	0.96	0.97	0.69	-0.76	0.89	0.91		0.24	0.98	-0.39	-0.33	-0.6	-0.14	-0.29	0.88	-0.06	0.94	-0.74	0.82	0.8	0.83	-0.62	0.95	0.95	0.72
Total Liab	0.34	0.2	-0.18	0.15	0.43	0.21	0.24		0.25	0.22	-0.57	0.2	0.16	-0.02	0.24	-0.33	0.23	0.03	0.47	0.15	0.36	0.12	0.22	0.12	0.15
Total Current Assets	0.96	0.97	0.68	-0.82	0.88	0.95	0.98	0.25		-0.35	-0.34	-0.59	-0.09	-0.24	0.92	-0.09	0.92	-0.73	0.84	0.8	0.8	-0.6	0.96	0.97	0.72
Short Term Debt	-0.34	-0.39	-0.6	0.4	-0.26	-0.32	-0.39	0.22	-0.35		-0.16	0.43	0.16	0.12	-0.35	-0.07	-0.38	0.4	-0.06	-0.23	-0.33	0.88	-0.36	-0.35	-0.21
Common Stock	-0.33	-0.26	0.34	0.07	-0.25	-0.28	-0.33	-0.57	-0.34	-0.16		-0.19	-0.54	-0.23	-0.13	-0.08	-0.22	0.11	-0.44	-0.29	-0.21	0.05	-0.23	-0.22	-0.15
Long Term Debt	-0.55	-0.61	-0.58	0.77	-0.49	-0.66	-0.6	0.2	-0.59	0.43	-0.19		0.32	0.29	-0.59	-0.14	-0.6	0.95	-0.55	-0.84	-0.44	0.66	-0.59	-0.56	-0.38
Good Will	-0.26	-0.25	-0.53	-0.04	-0.39	-0.25	-0.14	0.16	-0.09	0.16	-0.54	0.32		0.94	-0.39	0.22	-0.38	0.17	0.03	-0.16	-0.41	0.17	-0.19	-0.11	-0.47
Intangible Assets	-0.43	-0.39	-0.48	-0.01	-0.54	-0.39	-0.29	-0.02	-0.24	0.12	-0.23	0.29	0.94		-0.5	0.23	-0.52	0.24	-0.13	-0.3	-0.55	0.22	-0.31	-0.22	-0.62
Property Plant Equipment	0.94	0.94	0.78	-0.74	0.92	0.97	0.88	0.24	0.92	-0.35	-0.13	-0.59	-0.39	-0.5		-0.19	0.94	-0.68	0.76	0.73	0.84	-0.59	0.93	0.91	0.77
Current Deferred Revenue	-0.09	-0.03	-0.05	-0.1	-0.3	-0.12	-0.06	-0.33	-0.09	-0.07	-0.08	-0.14	0.22	0.23	-0.19		-0.06	-0.16	-0.04	0.1	0.02	-0.06	-0.04	-0.11	-0.21
Net Tangible Assets	0.99	0.99	0.78	-0.67	0.94	0.94	0.94	0.23	0.92	-0.38	-0.22	-0.6	-0.38	-0.52	0.94	-0.06		-0.71	0.8	0.78	0.93	-0.62	0.96	0.89	0.76
Long Term Debt Total	-0.69	-0.73	-0.53	0.82	-0.61	-0.78	-0.74	0.03	-0.73	0.4	0.11	0.95	0.17	0.24	-0.68	-0.16	-0.71		-0.71	-0.94	-0.54	0.7	-0.7	-0.67	-0.46
Capital Surpluse	0.83	0.81	0.39	-0.67	0.79	0.83	0.82	0.47	0.84	-0.06	-0.44	-0.55	0.03	-0.13	0.76	-0.04	0.8	-0.71		0.85	0.69	-0.42	0.83	0.75	0.42
Deferred Long Term Liab	0.78	0.79	0.44	-0.77	0.72	0.84	0.8	0.15	0.8	-0.23	-0.29	-0.84	-0.16	-0.3	0.73	0.1	0.78	-0.94	0.85		0.63	-0.59	0.75	0.7	0.53
Long Term Investments	0.93	0.9	0.73	-0.46	0.91	0.79	0.83	0.36	0.8	-0.33	-0.21	-0.44	-0.41	-0.55	0.84	0.02	0.93	-0.54	0.69	0.63		-0.51	0.88	0.76	0.75
Short Long Term Debt	-0.59	-0.64	-0.61	0.64	-0.51	-0.62	-0.62	0.12	-0.6	0.88	0.05	0.66	0.17	0.22	-0.59	-0.06	-0.62	0.7	-0.42	-0.59	-0.51		-0.59	-0.57	-0.39
Net Invested Capital	0.97	0.99	0.78	-0.76	0.9	0.93	0.95	0.22	0.96	-0.36	-0.23	-0.59	-0.19	-0.31	0.93	-0.04	0.96	-0.7	0.83	0.75	0.88	-0.59		0.95	0.69
Net Working Capital	0.91	0.94	0.75	-0.83	0.84	0.92	0.95	0.12	0.97	-0.35	-0.22	-0.56	-0.11	-0.22	0.91	-0.11	0.89	-0.67	0.75	0.7	0.76	-0.57	0.95		0.74
Capital Stock	0.78	0.75	0.59	-0.46	0.8	0.72	0.72	0.15	0.72	-0.21	-0.15	-0.38	-0.47	-0.62	0.77	-0.21	0.76	-0.46	0.42	0.53	0.75	-0.39	0.69	0.74

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Exelixis

According to the company's disclosures, Exelixis has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Exelixis ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Exelixis' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Exelixis' managers, analysts, and investors.

Environmental

Governance

Social

Exelixis Institutional Holders

Institutional Holdings refers to the ownership stake in Exelixis that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Exelixis' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Exelixis' value.

		Shares
Charles Schwab Investment Management Inc	2024-06-30	3.3 M
Aqr Capital Management Llc	2024-06-30	3.3 M
Norges Bank	2024-06-30	2.8 M
Bank Of New York Mellon Corp	2024-06-30	2.7 M
First Trust Advisors L.p.	2024-06-30	2.6 M
Jacobs Levy Equity Management, Inc.	2024-06-30	2.5 M
Fmr Inc	2024-06-30	2.3 M
Morgan Stanley - Brokerage Accounts	2024-06-30	2.3 M
Jupiter Asset Management Limited	2024-06-30	2.3 M
Blackrock Inc	2024-06-30	33.5 M
Vanguard Group Inc	2024-06-30	29.7 M

Exelixis Fundamentals

	Return On Equity	0.15
	Return On Asset	0.0851
	Profit Margin	0.17 %
	Operating Margin	0.43 %
	Current Valuation	7.37 B
	Shares Outstanding	285.25 M
	Shares Owned By Insiders	1.71 %
	Shares Owned By Institutions	87.40 %
	Number Of Shares Shorted	10.05 M
	Price To Earning	48.17 X
	Price To Book	3.86 X
	Price To Sales	4.08 X
	Revenue	1.83 B
	Gross Profit	1.55 B
	EBITDA	196.6 M
	Net Income	207.76 M
	Cash And Equivalents	1.53 B
	Cash Per Share	4.77 X
	Total Debt	189.94 M
	Debt To Equity	0.07 %
	Current Ratio	6.08 X
	Book Value Per Share	7.43 X
	Cash Flow From Operations	333.32 M
	Short Ratio	5.60 X
	Earnings Per Share	1.16 X
	Price To Earnings To Growth	2.26 X
	Target Price	29.8
	Number Of Employees	1.31 K
	Beta	0.54
	Market Capitalization	8.22 B
	Total Asset	2.94 B
	Retained Earnings	(173.35 M)
	Working Capital	923.68 M
	Current Asset	178.66 M
	Current Liabilities	52.25 M
	Net Asset	2.94 B

About Exelixis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Exelixis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exelixis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exelixis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:

How To Invest In Exelixis

Details

Is Exelixis Stock a good investment?

Details

What is Exelixis' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Exelixis Piotroski F Score and Exelixis Valuation analysis.

For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

2.08

Earnings Share

1.16

Revenue Per Share

6.636

Quarterly Revenue Growth

0.356

Return On Assets

0.0851

The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Exelixis Stock Z Score

Exelixis Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Exelixis Z Score Driver Correlations

Exelixis ESG Sustainability

Exelixis Institutional Holders

Exelixis Fundamentals

About Exelixis Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY